Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.
Ontology highlight
ABSTRACT: N-methyl-D-aspartate (NMDA) receptors mediate a slow component of excitatory synaptic transmission, are widely distributed throughout the central nervous system, and regulate synaptic plasticity. NMDA receptor modulators have long been considered as potential treatments for psychiatric disorders including depression and schizophrenia, neurodevelopmental disorders such as Rett Syndrome, and neurodegenerative conditions such as Alzheimer's disease. New interest in NMDA receptors as therapeutic targets has been spurred by the findings that certain inhibitors of NMDA receptors produce surprisingly rapid and robust antidepressant activity by a novel mechanism, the induction of changes in the brain that well outlast the presence of drug in the body. These findings are driving research into an en
SUBMITTER: Hanson JE
PROVIDER: S-EPMC10700609 | biostudies-literature | 2024 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA